Viking Therapeutics (VKTX) Tops Q4 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Dutch Bros Inc. (BROS) PT Raised to $90 at DA Davidson on Sales/Earnings Upside
• Playboy to buy back 16.6M shares from Fortress at $1.05 each